Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT

被引：0
|
作者：
Vrachimis, A. [1 ]
Weckesser, M. [1 ]
Schaefers, M. [1 ,2 ,3 ]
Stegger, L. [1 ]
机构：
[1] Univ Hosp Munster, Dept Nucl Med, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[2] Univ Munster, European Inst Mol Imaging, D-48149 Munster, Germany
[3] Univ Munster, DFG Cluster Excellence EXC Cells Motion 1003, D-48149 Munster, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷 / 06期
关键词：
PET/CT; ARTIFACTS; SCANNER;
D O I：
10.1007/s00259-016-3318-4
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1183 / 1184
页数：2
相关论文
共 50 条
  • [21] Negative predictive value of 124I-PET/CT imaging in patients affected by metastatic thyroid cancer and treated with 131I.
    Pettinato, C.
    Nanni, C.
    Celli, M.
    Allegri, V.
    Monari, F.
    Cima, S.
    Civollani, S.
    Zagni, P.
    Mazzarotto, R.
    Spezi, E.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S276 - S276
  • [22] Evaluation of 124I PET/CT and 124I PET/MRI in the management of patients with differentiated thyroid cancer
    Dercle, Laurent
    Deandreis, Desiree
    Terroir, Marie
    Leboulleux, Sophie
    Lumbroso, Jean
    Schlumberger, Martin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (06) : 1006 - 1010
  • [23] Evaluation of 124I PET/CT and 124I PET/MRI in the management of patients with differentiated thyroid cancer
    Laurent Dercle
    Désirée Deandreis
    Marie Terroir
    Sophie Leboulleux
    Jean Lumbroso
    Martin Schlumberger
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1006 - 1010
  • [24] Quantitative 124I-PET: Evaluation of Prompt Gamma Coincidence Correction on a Clinical PET/CT system
    Braad, P.
    Hansen, S. B.
    Thisgaard, H.
    Hoilund-Carlsen, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S498 - S498
  • [25] 124I-PET imaging of the ovarian cancer vascular marker TEM1
    Chacko, Ann-Marie
    Li, Chunsheng
    Muzykantov, Vladimir
    Coukos, George
    Divgi, Chaitanya
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [26] 124I-PET/CT-Guided Diagnosis and Personalized Treatment of Metastatic Papillary Thyroid Cancer to the Pancreas
    Wong, Bernadette Z. Y.
    Dickie, Graeme
    Garcia, Peter
    Scott, Dominique
    Pattison, David A.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : 337 - 339
  • [27] Comparison of radioiodine effective half-lives of thyroid remnants and lymph node metastases in patients with differentiated thyroid cancer using 124I-PET/CT imaging
    Nagarajah, J.
    Hartung, V.
    Rosenbaum-Krumme, S.
    Grabellus, F.
    Bockisch, A.
    Jentzen, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S113 - S113
  • [28] Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET
    L. S. Freudenberg
    G. Antoch
    A. Frilling
    W. Jentzen
    S. J. Rosenbaum
    H. Kühl
    A. Bockisch
    R. Görges
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 950 - 957
  • [29] Diagnosis of Struma Ovarii in a Patient with Papillary Thyroid Carcinoma - Verification via 124I-PET/US Fusion
    Freesmeyer, M.
    Schleussner, E.
    Winkens, T.
    ULTRASCHALL IN DER MEDIZIN, 2014, 35 (04): : 368 - 370
  • [30] Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography:: role of 124I-PET/CT and FDG-PET
    Freudenberg, L. S.
    Antoch, G.
    Frilling, A.
    Jentzen, W.
    Rosenbaum, S. J.
    Kuehl, H.
    Bockisch, A.
    Goerges, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (05) : 950 - 957
12345